Neuroone Medical Technologies Corp (NMTC) - Total Liabilities

Latest as of September 2025: $3.71 Million USD

Based on the latest financial reports, Neuroone Medical Technologies Corp (NMTC) has total liabilities worth $3.71 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Neuroone Medical Technologies Corp generate cash to assess how effectively this company generates cash.

Neuroone Medical Technologies Corp - Total Liabilities Trend (2010–2025)

This chart illustrates how Neuroone Medical Technologies Corp's total liabilities have evolved over time, based on quarterly financial data. Check Neuroone Medical Technologies Corp liquidity resilience to evaluate the company's liquid asset resilience ratio.

Neuroone Medical Technologies Corp Competitors by Total Liabilities

The table below lists competitors of Neuroone Medical Technologies Corp ranked by their total liabilities.

Company	Country	Total Liabilities
Abko Co. Ltd KQ:129890	Korea	₩46.18 Billion
Desert Gold Ventures Inc V:DAU	Canada	CA$105.17K
Carbon Streaming Corp NEO:NETZ	Canada	CA$1.82 Million
Chow Steel Industries Public Company Limited BK:CHOW	Thailand	฿674.73 Million
LIGHTON PA:ALTAI	France	€5.19 Million
IFCA MSC Bhd KLSE:0023	Malaysia	RM32.14 Million
Cipherlab Co Ltd TWO:6160	Taiwan	NT$426.98 Million
Gol Linhas Aéreas Inteligentes S.A NYSE:GOLLQ	USA	$45.83 Billion

Liability Composition Analysis (2010–2025)

This chart breaks down Neuroone Medical Technologies Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Neuroone Medical Technologies Corp (NMTC) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.44	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.53	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.34	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Neuroone Medical Technologies Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Neuroone Medical Technologies Corp (2010–2025)

The table below shows the annual total liabilities of Neuroone Medical Technologies Corp from 2010 to 2025.

Year	Total Liabilities	Change
2025-09-30	$3.71 Million	-18.36%
2024-09-30	$4.55 Million	+146.11%
2023-09-30	$1.85 Million	-42.58%
2022-09-30	$3.22 Million	+132.43%
2021-09-30	$1.38 Million	-48.60%
2020-09-30	$2.69 Million	+52.16%
2019-09-30	$1.77 Million	-61.64%
2018-09-30	$4.61 Million	+351.02%
2017-09-30	$1.02 Million	+1127.83%
2016-09-30	$83.33K	+134.11%
2015-09-30	$35.59K	+23.14%
2014-09-30	$28.91K	+57.48%
2013-09-30	$18.36K	0.00%
2012-09-30	$18.36K	+7.16%
2011-09-30	$17.13K	+27.33%
2010-09-30	$13.45K	--

About Neuroone Medical Technologies Corp

NASDAQ:NMTC USA Medical Devices

Market Cap

$217.50 Million

Market Cap Rank

#23299 Global

#4843 in USA

Share Price

$4.35

Change (1 day)

-7.45%

52-Week Range

$0.56 - $5.11

All Time High

$26.97